Ayr Wellness Inc.
AYRWF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.07 | -0.00 | 0.77 |
| FCF Yield | -29.06% | -9.33% | -117.36% | -14.68% |
| EV / EBITDA | -4.13 | 7.89 | -623.32 | 13.68 |
| Quality | ||||
| ROIC | -14.76% | -5.82% | -14.25% | 4.48% |
| Gross Margin | 38.11% | 43.66% | 42.99% | 38.62% |
| Cash Conversion Ratio | -0.03 | -0.10 | 0.13 | 1.64 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.23% | 9.04% | 39.54% | 68.17% |
| Free Cash Flow Growth | -21.70% | 87.13% | 24.36% | -687.67% |
| Safety | ||||
| Net Debt / EBITDA | -3.79 | 6.34 | -540.38 | 3.76 |
| Interest Coverage | -2.06 | -0.94 | -7.32 | -3.38 |
| Efficiency | ||||
| Inventory Turnover | 2.55 | 2.47 | 2.39 | 2.35 |
| Cash Conversion Cycle | 114.29 | 124.91 | 123.94 | 117.94 |